Development of a novel glucose‐dendrimer based therapeutic targeting hyperexcitable neurons in neurological disorders is a research paper published in Bioengineering & Translational Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: R01NS113140‐01
National Institutes of Health
Grant: 5R01NS113140-03
Targeted Therapies for Rett Syndrome
National Institutes of Health
Grant: 5R01EY033009-03
Innate immune system regulation of retinal regeneration
FWCI
1.15
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals